Addex Therapeutics (ADXN) Operating Margin: 2022-2025
Historic Operating Margin for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to 0.22%.
- Addex Therapeutics' Operating Margin rose 78035.00% to 0.22% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.64%, marking a year-over-year increase of 38066.00%. This contributed to the annual value of -681.82% for FY2024, which is 54276.00% down from last year.
- Per Addex Therapeutics' latest filing, its Operating Margin stood at 0.22% for Q2 2025, which was down 88.81% from 1.96% recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Operating Margin registered a high of 1.96% during Q1 2025, and its lowest value of -29,550.80% during Q4 2024.
- In the last 3 years, Addex Therapeutics' Operating Margin had a median value of -370.61% in 2023 and averaged -3,300.34%.
- Its Operating Margin has fluctuated over the past 5 years, first surged by 346,436bps in 2023, then plummeted by 2,907,514bps in 2024.
- Addex Therapeutics' Operating Margin (Quarterly) stood at -3,463.70% in 2022, then soared by 298,805bps to -475.65% in 2023, then plummeted by 2,907,514bps to -29,550.80% in 2024, then spiked by 78,035bps to 0.22% in 2025.
- Its Operating Margin stands at 0.22% for Q2 2025, versus 1.96% for Q1 2025 and -29,550.80% for Q4 2024.